
In this video, the first in a 6-part series, panelists discuss recent advancements in PsO management.
A 6-part video series tackling updates and unmet needs in scalp PsO in the wake of the May 2025 approval of roflumilast.

In this video, the first in a 6-part series, panelists discuss recent advancements in PsO management.

In this video, the second in a 6-part series, panelists discuss recent advancements in PsO management.

In this video, the third in a 6-part series, panelists discuss recent advancements in PsO management.

In this video, the fourth in a 6-part series, panelists discuss recent advancements in PsO management.

In this video, the fifth in a 6-part series, panelists discuss recent advancements in PsO management.

In this video, the last in a 6-part series, panelists discuss recent advancements in PsO management.